Safety of remibrutinib in chronic spontaneous urticaria: a pooled analysis of REMIX-1 and REMIX-2 trials

Journal of Allergy and Clinical Immunology: In Practice · Published 2026-06-01 · DOI 10.1016/j.jaip.2026.05.027

Free full text

Authors (24)

Ana Maria Giménez-Arnau, Artem Zharkov, Bin Yang, Atsushi Fukunaga, Michihiro Hide, Martin Metz, Giselle Mosnaim, Petra Staubach, Xing-Hua Gao, Vipul Jain, Alis Burciu, Bruno Cenni, Sibylle Haemmerle, Merin Kuruvilla, Songqiao Huang, David Ledieu, Jens Schuemann, Emil Scosyrev, Rahel Schneider, Elodie Incera, Karine Lheritier, Hanns-Christian Tillmann, Hichem Zouater, Sarbjit Saini

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Giménez-Arnau, A., Zharkov, A., Yang, B., et al. (2026). Safety of remibrutinib in chronic spontaneous urticaria: a pooled analysis of REMIX-1 and REMIX-2 trials. Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2026.05.027

Related articles

• Familial Mediterranean Fever Is Associated with Higher Atopic Morbidity: Evidence from a Country-Wide Case-Control Study · Journal of Allergy and Clinical Immunology: In Practice · 2026 · Same journal
• Effectiveness of Treatment With Tezepelumab in Patients With Severe Asthma, Smoking Asthmatics and Patients With Severe Asthma and COPD: A Real-World Cohort Study · Journal of Allergy and Clinical Immunology: In Practice · 2026 · Same journal
• The Management of NSAID-ERD Patients in the Current Treatment Landscape: Aspirin Desensitization, Biologics, Both, or Neither? · Journal of Allergy and Clinical Immunology: In Practice · 2026 · Same journal
• The spectrum of eosinophilic cellulitis (Wells’ syndrome): new insights based on 114 cases · Journal of Allergy and Clinical Immunology: In Practice · 2026 · Same journal
• Primary Immune Regulatory Disorders (PIRD): Tools for Diagnosis and Disease Activity Assessment to Guide Therapy · Journal of Allergy and Clinical Immunology: In Practice · 2026 · Same journal
• Biologic Therapy and Aspirin Reactivity in AERD: A Scoping Review. · Journal of Allergy and Clinical Immunology: In Practice · 2026 · Same journal
• Anaphylaxis and Epinephrine Use in Pregnancy · Journal of Allergy and Clinical Immunology: In Practice · 2026 · Same journal
• Allergic Fungal Rhinosinusitis: Distinct Clinical Features, Diagnostic Challenges, and Evolving Therapeutic Strategies · Journal of Allergy and Clinical Immunology: In Practice · 2026 · Same journal
• Omalizumab-assisted venom immunotherapy: The need for standardized qualification and protocol-dependent risk assessment · Journal of Allergy and Clinical Immunology: In Practice · 2026 · Same journal
• Dupilumab Efficacy in Children With Uncontrolled, Moderate-to-Severe, Type 2 Asthma by Allergen Sensitization Level · Journal of Allergy and Clinical Immunology: In Practice · 2026 · Same journal